Evidence map›Paper›PMID 37577340›Full record

ArticleInternational cancer conference journal2023

Radiologic and pathologic correlation of a renal venous hemangioma.

Alperen Elek, Jung Woo Kwon, Sena Ertugrul, Nisa Cem Oren

Open access · greenAbstract read
In one paragraph

Article in International cancer conference journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Renal venous hemangioma: Report of a rare case.Experimental and therapeutic medicine · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Alperen ElekFaculty of Medicine, Ege University, Erzene Ave, 35040 Bornova, Izmir Turkey.ORCID 0000-0001-5414-6548
Jung Woo KwonFaculty of Medicine, Department of Pathology, University of Chicago, 5801 S. Ellis Ave, Chicago, IL 60637 USA.
Sena ErtugrulGulhane Faculty of Medicine, University of Health Sciences, Emrah Ave, Etlik, Kecioren, 06018 Ankara, Turkey.ORCID 0000-0001-7699-2710
Nisa Cem OrenFaculty of Medicine, Department of Radiology, University of Chicago, 5801 S. Ellis Ave, Chicago, IL 60637 USA.ORCID 0000-0003-4126-6297
University of Chicago · USEge University · TRTurkish Armed Forces · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal hemangiomas, including the rare subtype of venous hemangioma, are typically non-cancerous, often asymptomatic, and usually discovered incidentally during imaging studies. Here, we report a unique case of a 59-year-old African-American female with a renal venous hemangioma that initially mimicked papillary-type renal cell carcinoma (RCC-pt) on imaging studies. The patient's presentation included a long history of rectal bleeding and an incidental discovery of a hypoattenuating mass in the left kidney during a contrast-enhanced CT scan. Renal MRI revealed a 3.5 cm left renal lower pole mass, presenting as heterogeneously hyperintense on T1-weighted images and hypointense on T2-weighted images, with gradual mild enhancement post-contrast. Subsequent total nephrectomy confirmed the histopathological diagnosis of a venous hemangioma. This case underlines the need for recognizing unique imaging features of renal venous hemangiomas, contributing to the differential diagnosis of T2 dark hypoenhancing renal masses. Correct interpretation may prevent unnecessary invasive procedures and operations, thereby improving patient management and outcomes.

Indexed as

CTHemangiomaMRIPathologyRenalVenous

Identifiers

PMID37577340
PMCPMC10421804
OpenAlexW4385519636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.